Furthermore, in the circulation, both classical and nonclassical monocytes exhibited low expression of SIGLEC1, with no difference between cancer and noncancer patients, indicating the specificity of SIGLEC1 to macrophages/TAMs.69 This evidence concerns the gene SIGLEC1 and cancer.